Citadel Advisors’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.98M Buy
611,195
+234,097
+62% +$1.91M ﹤0.01% 1921
2025
Q1
$2.96M Buy
377,098
+16,504
+5% +$130K ﹤0.01% 2221
2024
Q4
$5.37M Buy
360,594
+42,723
+13% +$636K ﹤0.01% 1744
2024
Q3
$4.86M Sell
317,871
-149,292
-32% -$2.28M ﹤0.01% 1791
2024
Q2
$7.11M Buy
467,163
+112,242
+32% +$1.71M ﹤0.01% 1432
2024
Q1
$6.7M Buy
354,921
+78,997
+29% +$1.49M ﹤0.01% 1555
2023
Q4
$5.27M Sell
275,924
-9,923
-3% -$190K ﹤0.01% 1615
2023
Q3
$5.13M Sell
285,847
-449,782
-61% -$8.07M ﹤0.01% 1599
2023
Q2
$14.9M Sell
735,629
-1,030,379
-58% -$20.9M ﹤0.01% 960
2023
Q1
$32.2M Buy
1,766,008
+1,122,779
+175% +$20.5M 0.01% 625
2022
Q4
$13.3M Buy
643,229
+616,739
+2,328% +$12.8M ﹤0.01% 1114
2022
Q3
$693K Sell
26,490
-25,393
-49% -$664K ﹤0.01% 3774
2022
Q2
$1.32M Buy
51,883
+31,975
+161% +$810K ﹤0.01% 3123
2022
Q1
$628K Sell
19,908
-141,902
-88% -$4.48M ﹤0.01% 4204
2021
Q4
$6.55M Buy
161,810
+133,722
+476% +$5.41M ﹤0.01% 1860
2021
Q3
$979K Sell
28,088
-14,061
-33% -$490K ﹤0.01% 3805
2021
Q2
$1.16M Sell
42,149
-11,003
-21% -$302K ﹤0.01% 3832
2021
Q1
$1.49M Sell
53,152
-42,361
-44% -$1.19M ﹤0.01% 3501
2020
Q4
$2.48M Sell
95,513
-20,471
-18% -$531K ﹤0.01% 2352
2020
Q3
$1.99M Sell
115,984
-254,042
-69% -$4.35M ﹤0.01% 2287
2020
Q2
$9.16M Buy
370,026
+338,436
+1,071% +$8.37M ﹤0.01% 1143
2020
Q1
$439K Sell
31,590
-25,494
-45% -$354K ﹤0.01% 3503
2019
Q4
$577K Buy
57,084
+2,042
+4% +$20.6K ﹤0.01% 3453
2019
Q3
$501K Sell
55,042
-14,495
-21% -$132K ﹤0.01% 3467
2019
Q2
$553K Buy
69,537
+52,018
+297% +$414K ﹤0.01% 3457
2019
Q1
$219K Buy
+17,519
New +$219K ﹤0.01% 3914